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Abstract The interaction of the anti-apoptotic members of the
Bcl-2 family with mitochondria, through their hydrophobic C-
terminus, has been proposed to play a crucial role in the
execution phase of apoptosis. We report here that a substitution
of the C-terminal end of pro-apoptotic bax by that of anti-
apoptotic bcl-xL (baxCxL) does not modify its association with
mitochondria in human and rat cells or in Saccharomyces
cerevisiae. In addition, while bax sensitizes these cells to
apoptotic stimuli, the construct baxCxL does not affect the
apoptotic response in transfected cells. These results suggest that
the C-terminus of bax plays an important role in apoptosis
independently of its membrane addressing/targeting mechan-
ism. ß 2000 Federation of European Biochemical Societies.
Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Members of the Bcl-2 proto-oncogene family are central
regulators of the apoptotic programme [1^4]. The Bcl-2 gene
encodes for a protein of 26 kDa which associates mainly with
the mitochondrial outer membrane [1^4]. The Bcl-2 family
includes both pro- and anti-apoptotic proteins which share
several homologous structural domains such as the Bcl-2 Ho-
mology domains BH1, BH2 and BH3, and a stretch of hydro-
phobic amino acid residues located at the C-terminus [1^4].
The interaction of the latter domain with biological mem-
branes is supposed to be a determinant in the subcellular
localization of these proteins [1^4]. The BH domains are in-
volved in the homodimerization or the heterodimerization of
members of the Bcl-2 protein family among themselves or
with other proteins, a property which is supposed to regulate
their apoptotic function [1^4]. It has also been reported that
bcl-2 and bax could form ionic channels in arti¢cial mem-
branes [4,5]. It has thus been postulated that Bcl-2 family
members could exert their functions either through protein/
protein interactions when anchored in the mitochondria
through their hydrophobic C-termini or as pore-like mem-
brane-embedded protein [2].
Bax, a pro-apoptotic member of this family, is normally
located in the cytosol of healthy cells and is targeted to mi-
tochondria upon induction of apoptosis [6,7]. The role of the
C-terminus of bax in its integration into membranes and its
pro-apoptotic function is unclear. Contradictory results of the
e¡ect of the deletion of the C-terminus of bax have been
reported, both in mammals and in Saccharomyces cerevisiae
[8^11]. We have recently shown, using a cell-free system, that
the substitution of the C-terminus of bax by the equivalent
segment of bcl-xL results in an e⁄cient, although incomplete,
association of the fusion protein baxCxL with mitochondria
[8]. In the present work, we have investigated the in£uence of
this C-terminal substitution on mitochondrial targeting and in
pro-apoptotic function after stable expression in human and
rat cell-lines or in S. cerevisiae.
2. Materials and methods
2.1. Reagents
Unless speci¢ed, all reagents used in this study were from Sigma
(St. Louis, MO, USA). Monoclonal bax antibody (clone 4F11) was
from Immunotech (France) and polyclonal bcl-xL antibody (B26630)
was from Transduction Laboratories (Pharmingen, France); antibod-
ies were used at a concentration of 1 and 5 Wg/ml, respectively. The
mitochondria-selective probe Mitotracker-Green FM was obtained
from Molecular Probes (Interchim, France) and £uorogenic peptide
Ac-DEVD-AMC was from Bachem (France).
2.2. Plasmids and cell transfections
The bax mutants with C-terminus substituted by that of bcl-xL
(baxCxL), or deleted (baxvC) were obtained as previously described
[8] and subcloned into pRcCMV plasmid (Clontech, France). Bax and
baxCxL were also subcloned into yeast tet-o¡-driven expression vec-
tor pCM189 carrying an URA3 selection marker, as described in [12].
The rat glioma A15A5 and human leukemic K562 cell-lines were
transfected with control pRcCMV vector, pRcCMV-bax or
pRcCMV-baxCxL. Plasmid DNA (5 Wg) was introduced into 106
A15A5 or K562 cells by electroporation (GenePulser, BioRad) using
200 V/cm and 250 WF, transfected cells were selected in a medium
containing G418 (250 Wg/ml). Cells overexpressing human baxK were
analyzed by immunoblot using the bulk of transfected K562 cells or in
three di¡erent clones in the case of A15A5 cells.
Parental yeast strain W303-1A (mata, ade1, his3, leu2, trp1, ura3)
was transformed as described in [12] with pCM189-based plasmids
expressing Bax or BaxCxL. Transformations were controlled by poly-
merase chain reaction on NaOH-lyzed colonies.
2.3. Cell fractionation and confocal analysis
Transfected K562 or A15A5 (2U106) cells were cultured in the
presence or in the absence of staurosporine (1 WM), paclitaxel
(5 Wg/ml) or 1 min UV-B treatment. At di¡erent times after the in-
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duction of apoptosis, the cells were collected and centrifuged at
800Ug for 10 min at 4‡C. The cell pellets were washed with ice-
cold phosphate-bu¡ered saline (PBS), then resuspended in v/v CEB
(250 mM sucrose; 50 mM HEPES pH 7.4, 50 mM KCl, 2 mM
MgCl2, 1 mM dithiothreitol, 10 WM cytochalasin B, 1 mM EGTA
and 1 mM PMSF) as previously described [13]. Cells were allowed to
swell for 30 min on ice. The cells were then homogenized with 30
strokes in a 2 ml glass Dounce homogenizer. The homogenates were
centrifuged at 800Ug for 10 min at 4‡C and the resulting supernatants
centrifuged a further 15 min at 13 000Ug at 4‡C to obtain the mito-
chondrial pellets (P13). These supernatants were then centrifuged at
100 000Ug for 30 min in an airfuge (Beckman, USA) and the resulting
cytosolic fraction was further referred to as the S100. Bax and bcl-xL
were detected in mitochondrial pellets and S100 using standard im-
munoblot methods.
The transfected cells were used for confocal and apoptosis analysis.
For confocal analysis, the transfected cells were incubated with 25
Wg/ml Mitotracker-Green FM for 30 min at 37‡C, washed with PBS
then ¢xed with 4% paraformaldehyde^0.19% picric acid in PBS for
30 min at room temperature. After saturation with 3% bovine serum
albumin (BSA) in PBS, the cells were incubated with monoclonal anti-
bax for 1 h at room temperature. After extensive washing, the second
antibody, anti-mouse IgG coupled to rhodamine was added overnight
at 4‡C. Images were collected on a Leica TCS NT microscope with a
100U1.3 NA Fluotar objective (Leica, France).
2.4. Quanti¢cation of apoptosis
2.4.1. Lactate dehydrogenase (LDH) activity. Cell death was as-
sessed by measuring the LDH activity released into the medium by
healthy or by apoptotic cells. The LDH activity was measured using a
cytotox 960 assay from Promega (France) according to the manufac-
turer’s instructions.
2.4.2. DEVDase. Apoptosis was determined by measuring the cas-
pase-3-like activity after induction of apoptosis as previously de-
scribed [8,13]. In whole cell experiments, cells were washed several
times with PBS, plated in 96-well plates and the caspase-3 £uorogenic
substrate (Ac-DEVD-AMC) was added in the presence of 0.01% Tri-
ton X-100.
2.5. Yeast experiments
Yeast cells were grown aerobically in a semi-synthetic YNB me-
dium (0.67% yeast nitrogen base, 0.1% ammonium sulfate, 0.5% po-
tassium phosphate, 0.2% Drop-mix) supplemented with 2% lactate as
a carbon source, auxotrophic requirements and 1 Wg/ml doxycycline
to prevent the expression of bax-derived proteins. The induction was
induced by washing the cells three times then resuspending in the
same medium without doxycycline. Growth was followed by the op-
tical density of the cultures at 550 nm.
The localization of bax-derived proteins was observed in cells
grown as above, after a 24 h induction of protein synthesis. The
mitochondrial fraction was puri¢ed from spheroplasts generated by
zymoliase treatment of the cells as described in [11]. Proteins were
separated by SDS^PAGE, transferred on ProBlott membranes and
Western blotting was done with a primary anti-bax monoclonal anti-
body directed against a peptide corresponding to the position 150^165
of bax (Calbiochem, France) and a secondary anti-mouse/peroxidase
antibody (Jackson laboratories) and revealed by enhanced chemilumi-
nescence (Amersham).
3. Results
3.1. Expression of bax, baxvC and baxCxL in healthy and in
apoptotic K562 cells
The human leukemic K562 cells were stably transfected
with wild-type human bax (bax-K), baxvC (deletion of amino
acid 172^193 of bax-K) or baxCxL (human baxvC fused with
the amino acids 213^234 of human bcl-xL). The sequences of
both bax and bcl-xL C-termini are illustrated in Fig. 1A. Cells
were transfected with untagged bax constructs as we have
previously shown that the addition of a HA-tag enhanced
the association of bax with mitochondria [8]. We used the
bulk of transfected K562 cells and the e⁄ciency of the trans-
fection was estimated by immunoblotting of bax. Although
K562 cells expressed high amounts of endogenous bax, bax
transfected cells exhibited a signi¢cant increased expression
(Fig. 1B). Cells were fractionated as described in Section 2
and the e⁄ciency of the fractionation was determined using
actin as a cytosolic marker and the subunit IV of cytochrome
c oxidase as a mitochondrial marker (data not shown). In
healthy cells, most of the bax was found in the cytosol and
only a small proportion was associated with mitochondria. As
shown in Fig. 1, the addition of the transmembrane segment
of bcl-xL did not enhance bax subcellular distribution. This
result suggested that, in contrast to that observed in the cell-
free system, the addition of the C-terminal end of bcl-xL did
not enhance the mitochondrial binding of bax-K. However,
this marginal association of bax or baxCxL with mitochon-
dria in K562 cells appeared to depend upon the overexpres-
sion of bax and the presence of a hydrophobic C-terminus
since no association of bax with mitochondria was found in
pRcCMV or baxvC transfected cells (Fig. 1B). Quite interest-
ingly, bcl-xL which is highly expressed in K562, was present in
both cytosolic and mitochondrial fractions, a repartition also
found by Hsu et al. [6] in thymocytes (Fig. 1B). The induction
of apoptosis by a brief UV-B treatment (see Section 2) caused
the translocation of almost all of the cytosolic bax and bcl-xL
to mitochondria. It should be noted that the nature of the C-
terminus of bax did not in£uence the e⁄ciency of this trans-
location (Fig. 1C). These results suggested that the addition of
Fig. 1. In£uence of the bcl-xL transmembrane segment on bax sub-
cellular localization in the human leukemic K562 cell-line. A: Se-
quences of the C-terminus of human bax (amino acid 172^193) and
bcl-xl (amino acid 213^234). B: Cell fractionation of control trans-
fected K562 cells was performed as described in Section 2. P13 and
S100 fractions were analyzed by immunoblot using antibodies raised
against human bax. The same concentration of total S100 and P13
were used in order to visualize the actual cellular ratio. C: Similar
analysis using apoptotic UV-B treated transfected cells.
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the C-terminal end of bcl-xL did not a¡ect its subcellular
localization in either healthy or apoptotic cells.
We induced apoptosis by several di¡erent stimuli (paclitax-
el, UV or staurosporine) and cell death was assessed by the
release of the cytosolic enzyme LDH into the culture media
(Section 2). As illustrated in Fig. 2, the overexpression of bax
sensitized K562 cells to all death stimuli while the presence of
baxCxL had no e¡ect on the rate or the extent of LDH re-
lease. However, in untreated cells, the extent of LDH-release
remained elevated in both baxCxL and bax transfected cells
compared to pRcCMV transfected cells (Fig. 2A). This result
suggests a ‘constitutive’ toxicity of baxCxL similar to that
observed with bax-K.
We quanti¢ed the level of apoptosis in these cells using the
degradation of the £uorogenic peptide Ac-DEVD-AMC, a
caspase-3 substrate, as previously described [8]. The results
of the DEVDase assay were similar to that observed in the
LDH assay, demonstrating a potentiation of apoptosis by
bax. The di¡erence between pRcCMV transfected cells and
bax transfected cells was signi¢cant (P = 0.0397) but the di¡er-
ence between pRcCMV transfected cells and baxCxL was not
signi¢cant (P = 0.342; Fig. 2E). It should be noted that no
signi¢cant di¡erences in the DEVDase activity were observed
among untreated cells (P = 0.42).
3.2. BaxCxL does not sensitize A15A5 cells to apoptosis
induced by di¡erent stimuli
In this study, we used three di¡erent clones of the rat
A15A5 cell-line transfected with either pRcCMV, human
bax (pRcCMV bax) or the baxCxL construct (pRcCMV-
baxCxL). Bax and baxCxL transfected cells exhibited similar
levels of bax protein as well as a similar distribution as deter-
mined by immunoblots using subcellular fractionation (data
not shown) or by laser confocal microscopy (Fig. 3). In
healthy cells, bax-K and baxCxL appeared to be mostly cyto-
solic with a preferential perinuclear localization (Fig. 3). Ap-
optosis was induced by di¡erent stimuli (UV-B treatment,
staurosporine or paclitaxel) and cell death was determined
by LDH release and by DEVDase activity. Induction of ap-
optosis induced a redistribution of bax-K and baxCxL to the
mitochondrial membrane as previously shown in K562 cells
(data not shown). We found that, as in K562 cells, transfec-
tion with bax-K sensitized A15A5 cells to all apoptotic stimuli
with no di¡erences between the response of pRcCMV and
baxCxL transfected cells to apoptotic inducers, as illustrated
in the case of cell death induced by a short UV-B treatment
which was quanti¢ed using a DEVDase assay. As shown in
Fig. 3G, the DEVDase activity was signi¢cantly increased in
all transfected cells 24 h after the UV-B treatment. Nonethe-
less, a marked di¡erence was observed between control
(pRcCMV) and bax transfected cells as the DEVDase activity
was two-fold higher in the latter cells (P = 0.0481). On the
other hand, similar DEVDase activities were induced by the
UV-B treatment in control pRcCMV and in baxCxL trans-
fected A15A5 cells (P = 0.645). These results demonstrate that
the ectopic expression of baxCxL does not potentiate apopto-
tic induction in A15A5 cells as observed previously in human
cells.
3.3. Expression of bax and baxCxL in yeast
Yeast S. cerevisiae do not spontaneously undergo apoptosis
and do not contain any analogs of the Bcl-2 family members,
including bax. However, the heterologous expression of bax in
yeast induced a cell death which was accompanied by typical
characteristics of apoptosis such as cytochrome c release [14],
DNA laddering and phosphatidylserine exposure [15]. This
mortality and the accompanying phenotypes were prevented
by the co-expression of bcl-2 or bcl-xL. When expressed in
yeast, both bax and baxvC have a mitochondrial localization
and there was no signi¢cant di¡erence between their lethal
e¡ect [11].
Bax and baxCxL were expressed under the control of the
tet-o¡ promoter. Under these conditions, the expression of
bax induced a growth arrest of yeast cells (Fig. 4) followed
by lethality, as already described [12]. In contrast, the expres-
sion of baxCxL did not induce any growth arrest of yeast cells
(Fig. 4). Cell death as assayed by colony forming capacity
after 24 h of induction of bax expression was 83% for bax
transfected yeast and only 5% for baxCxL transfected cells.
The level of expression and the amount of both proteins in
the mitochondrial fraction were identical (data not shown).
Interestingly, the short form of bax, which appeared after a
N-terminal cleavage accompanying mitochondrial transloca-
tion in yeast [11], was still present, and in even higher pro-
portions, in baxCxL transfected cells (data not shown).
These results demonstrate that, as in rat and human cells,
the substitution of the C-terminus of bax by the equivalent
Fig. 2. In£uence of the bcl-xL transmembrane segment on bax pro-
apoptogenic activity in K562 cell-line. LDH activity release into the
culture medium of healthy (A), paclitaxel- (B), staurosporine- (C) or
UV-B-treated K562 cells (D) (cf. Section 2). bax (F), baxCxL (E)
and pRcCMV (a) transfected cells. Experiments illustrated are rep-
resentative of at least three di¡erent experiments. DEVDase activity
in UV-B treated K562 cells, * indicated statistically signi¢cant dif-
ferent activities (E), data obtained from three independent experi-
ments.
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sequence of bcl-xL does not impair the mitochondrial local-
ization of the protein but prevents its cytotoxic e¡ect.
4. Discussion
Deletion of the C-terminal end of bcl-2 inhibits its anti-
apoptotic function [16,17] and its substitution by that of cyto-
chrome b5 relocalizes bcl-2 to the endoplasmic reticulum
which elicits its anti-apoptotic property towards some apopto-
tic stimuli [18]. In some cells, bax appears to be essentially
cytosolic with only a small percentage of the protein associ-
ated with mitochondria [7]. The bulk of cytosolic bax is trans-
located to the mitochondria upon induction of apoptosis [6]
and this translocation is one of the earliest rate-limiting steps
in the executive phase of apoptosis [7]. Thus, the ‘proper’
mitochondrial localization of members of the Bcl-2 family is
important in the control of apoptosis. The signals involved in
bax addressing and incorporation into mitochondrial mem-
branes are still unknown. It has been proposed that the C-
terminus of bax is involved in its association with mitochon-
dria, on the basis of its hydrophobic pro¢le and by analogy
with the equivalent segment in bcl-2 [1^4]. However, con£ic-
tual results on the importance of this segment in both bax
pro-death function and intracellular localization in mammals
and in yeast have recently been published [8^11]. Bcl-xL, like
bcl-2, appears to be mostly mitochondrial [19] and this local-
ization relies on its hydrophobic C-terminal [20]. Hsu et al. [6]
reported that a signi¢cant part of bcl-xL is cytosolic in
healthy cells and, like bax, translocates to mitochondria dur-
ing apoptosis. We have recently observed that, in a cell-free
system, the C-terminus of bax is not an addressing mitochon-
drial signal and that the substitution of this segment by that
of bcl-xL leads to the binding of the chimeric bax protein
(baxCxL) to mitochondria [8]. In this work, we used this
construct as a putative constitutively mitochondria-bound
bax. In the rat and human cellular models used in this study,
this construct was preferentially not associated with mito-
chondria but, like wild-type bax-K and bcl-xL, remained
partly cytosolic and was translocated to the mitochondria
upon induction of apoptosis (Figs. 1 and 3). In yeast, bax-K
and baxCxL have a similar mitochondrial localization (data
not shown). Therefore, in the three cellular models, the sub-
stitution of the C-terminus of bax by that of bcl-xL does not
a¡ect the localization of the protein.
Fig. 3. In£uence of the bcl-xL transmembrane segment on bax subcellular localization and pro-apoptogenic activity in the rat glioblastoma
A15A5 cell-line. A^F: Confocal analysis of bax intracellular localization: double labelling with a £uorescent marker of mitochondria (Mito-
tracker, green) and bax (red) in A15A5 cells transfected with pRcCMV (A: mitotracker, B: bax); Bax (C: mitotracker, D: bax); BaxCxL (E:
mitotracker, F: bax). Each image is representative of at least three di¡erent experiments. G: Induction of apoptosis in pRcCMV, bax or
baxCxL transfected A15A5 cells. The DEVDase activity was measured, in three di¡erent clones for each plasmid, 24 h after the induction of
apoptosis by a brief UV-B treatment (Section 2). ** indicated statistically signi¢cant di¡erent activities, data obtained from three independent
experiments.
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However, the substitution had a profound e¡ect on bax-
activity as it abolished its pro-apoptotic function in all cell
types studied. Recently, Nechustan et al. [21] showed that the
C-terminus of bax required a substitution at a strategic serine
to become an addressing/anchoring signal. Interestingly de-
pending on the nature of the amino acid substituted for the
serine the mutation could provoke a gain or a loss of function
[21]. Bax undergoes conformational changes that are required
for its integration into mitochondrial membrane as a homo-
dimer [21^23]. The N-terminus disengagement, identi¢ed by
its recognition by speci¢c antibodies, has been postulated to
be an important step in bax activation in mitochondria [22]. It
should be noted that in mammalian cells, once bound to mi-
tochondria, we observed that baxCxL exposed its N-terminus
as does wild-type bax (data not shown). In yeast, a N-terminal
cleavage of bax occurs during mitochondrial translocation
and this cleavage was also found with baxCxL, suggesting
that the accessibility of baxCxL to the protease responsible
for this cleavage is the same as for bax.
Another important putative feature in bax function is its
interaction with the ATP/ADP translocator (ANT) of the mi-
tochondrial inner membrane [24]. Interestingly, we observed
an increase in the expression of ANT in bax transfected cells
but not in baxCxL transfected cells (unpublished results). One
could hypothesize that the presence of the C-terminus of
bcl-xL hinders the capacity of bax to interact with ANT
and thus its ability to induce apoptosis. In conclusion, our
data support the idea that the C-terminus of bax could play
an essential role in the control of its pro-apoptotic activity but
not in its addressing to mitochondria.
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Fig. 4. In£uence of the bcl-xL transmembrane segment on bax cyto-
toxicity and localization in S. cerevisiae. Cells were grown aerobi-
cally in YNB-lactate medium and induction of bax-K or baxCxL ex-
pression was induced by doxycycline-removal. A: Growth of yeast
cells containing a plasmid expressing bax or baxCxL without or
with induction of the proteins compared to that of yeast baxCxL.
Doxocyclin induction: bax b, baxCxL a ; absence of induction; bax
F, baxCxL E.
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